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It is important to study the stability of plant extracts used as active ingredients in phytotherapic 
medicine, as degradation of the active principles directly affects the efficacy and safety of these 
products. Therefore, a stability study of the hydroalcoholic extract of the species: Mikania 
glomerata and Mikania laevigata was conducted in order to determine the speed of degradation 
and shelf life of these extracts, which are incorporated in cough syrup in Brazil. Leaves of 
both species were dried in an oven or by lyophilization (freeze-dried). Hydroalcoholic extracts 
underwent both accelerated stability study of six months and long-term stability study for 12 
months. Samples were stored at different temperatures and every three months were analysed 
by ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) to monitor 
their chemical profile, quantifying coumarin and chlorogenic acid. For all conditions of the study, 
a reduction of the content of the chemical marker of this species, coumarin, greater than 5% was 
observed, so a shelf life of two years cannot be assigned to the hydroalcoholic extracts of these 
species as observed in commercial extracts.
Keywords: Mikania glomerata Spreng.. Mikania laevigata Sch. Bip. ex Baker.. Guaco. Ultra-high 
performance liquid chromatography-mass spectrometry. Stability test. Coumarin. Chlorogenic acid.
INTRODUCTION
In Brazil, two species of Mikania, popularly known 
as guaco are easily available and widely used in popular 
medicine in extemporary preparations such as tea and 
homemade syrups for the treatment of diseases of the 
airways, due to their bronchodilator effect (Silva et 
al., 2008). Mikania glomerata Spreng. and Mikania 
laevigata Sch. Bip. ex Baker extracts are also found in 
industrialized syrups, which therefore need to have a 
longer and clearly defined shelf life (Gasparetto et al., 
2010). To guarantee the efficacy, safety and quality 
of herbal medicines is often a challenge (Pinto et al., 
2002). By virtue of the therapeutic properties attributed 
to guaco, syrup and oral solution of M. glomerata were 
included in the reference list of medicines for primary 
health care in 2007 (Brasil, 2007). Therefore, herbal 
medicines based on guaco are used extensively in the 
public health system and by the general population 
(ANVISA, 2008; Brasil, 2006). 
A norm, published by the Brazilian government 
agency classified 36 medicinal plants as safe and effective 
and only the manufacturing process and quality control 
need be detailed for their registration. These plants 
have streamlined registration, including M. glomerata, 
enabling their industrial production (ANVISA, 
2008). Another resolution establishes the minimum 
requirements for the registration of herbal medicine and 
lists the documents required for registration (ANVISA, 
2010), including results of accelerated stability study or 
the long-term stability studies, according to Government 
standards (Brasil, 2005).
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Stability tests aim to establish the shelf life, period 
of use in packaging and storage conditions of a specific 
drug. In general, the shelf life of a product is determined 
by the long-term stability study of 12 months, but for 
purposes of registration, a 6 month-study of accelerated 
stability is accepted (Brasil, 2005). Although this 
test is not mandatory for active components (such as 
guaco extracts used in syrups), commercial guaco 
extracts (tinctures and liquid extracts of M. glomerata 
and M. laevigata) were acquired with expiration dates 
indicating shelf lives of over 2 years, possibly without 
the evaluation of their stability. 
Given the lack of studies evaluating the stability 
of extracts of M. glomerata and M. laevigata, prepared 
according to pharmacopoeia standards, the objective of 
this work was to study the stability of hydroalcoholic 
extracts of M. glomerata and M. laevigata in accordance 
with the provisions of the Guide for conducting Stability 
Studies Resolution (Brasil, 2005) accompanying the 
content of their official chemical marker, coumarin.
MATERIAL AND METHODS 
Material
Specimens of M. glomerata and M. laevigata 
growing in the experimental field of the Department of 
Plant Biology at the Institute of Biology, UNICAMP, 
and their exsiccates are deposited in the herbarium of the 
Universidade Estadual de Campinas under registration 
UEC No. 102047 for M. glomerata and No. 102046 for 
M. laevigata. 
Leaves of both species were collected in the 
morning and divided into two groups, the first being 
subjected to drying in an oven with air circulation at 
40 ºC for 50 hours. The second group was frozen and 
lyophilized for 50 hours. The dried leaves of the two 
groups were ground (0.84 mm particle size). The 
extracts were prepared following the First Brazilian 
Pharmacopoeia (Brasil, 1929) using a proportion of 
200 g of the powdered leaves to 1000 mL of 67% (v/v) 
alcohol solution (Ecibra, Brazil). After extraction, an 
aliquot of 10 mL was dried at 105 ºC until constant 
weight to determine the solids content. 
Chromatographic method
For the chromatographic evaluation the validated 
method (Melo, Sawaya, 2015) was used. An ultra-high 
performance liquid chromatographer coupled to a triple 
quadrupole mass spectrometer, Acquity UPLC-TQD 
(Micromass, Waters, Manchester, England) was used with 
a Waters Acquity BEH C18 column (2.1 mm x 50 mm, 
1.7 µm particles) and oven temperature of 30 ºC. Elution 
was performed at a flow of 200 µL/min with solvent A - 
purified water (Milli-Q) with 0.1% formic acid and solvent 
B - Acetonitrile HPLC grade (JT Baker, PA, USA). The 
elution gradient started with 10% solvent B increasing 
to 25% B in 4 minutes, then 100% B in 8 min; 100% B 
was maintained until 8.5 min, the returning to the initial 
conditions and stabilizing up to 10 min. MS detection 
was performed in positive and negative ion mode with 
electrospray ionization under the following conditions: 
3000 V capillary ± cone ± 35 V, source temperature 150 ºC 
and desolvation temperature of 300 ºC. 
Before the injection, the extracts were diluted with 
purified water (Milli-Q) at a ratio of 1 part to 2 parts 
of the extract and 2 µL of each sample was injected. 
The concentration of coumarin and chlorogenic acid 
in the extracts was quantified using a calibration curve 
of coumarin (Sigma-Aldrich) and chlorogenic acid 
(Sigma-Aldrich) in 70% ethanol solutions and blank 
plant matrix (Melo, Sawaya, 2015). Chlorogenic acid 
was analysed in the negative ion mode and coumarin in 
positive ion mode.
Results were analysed using GraphPad Prism, 
version 5.00 for Windows (Microsoft), GraphPad 
Software, San Diego, California, USA, expressed as 
mean ± standard error and were compared by Tukey test 
at 5% probability (p<0.05).
Stability Study
The stability study (Brasil, 2005) of the hydroalcoholic 
extracts was carried out in glass bottles. The extracts 
were stored in clear glass bottles for 12 months at ambient 
temperature of 22 ºC in the presence and absence of light. 
For the 6-month accelerated study, samples were kept at 
40 ± 2 ºC without controlled humidity, as determined by 
the guide for conducting stability studies. For the long-
term study, samples were kept at 30 ± 2 ºC for 12 months 
without controlled humidity. After the storage period, the 
initial volume of the extracts was supplemented with a 
solution of 70% ethanol and then diluted in purified water 
(Milli-Q) at a ratio of 1: 2 extract: water prior to analysis 
by UHPLC- MS. 
In addition to the extracts prepared in our lab, 
samples of commercial extracts obtained from a 
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distributor (guaco tincture and guaco fluid extract) were 
also subjected to an accelerated stability study. The 
concentration of coumarin and chlorogenic acid was 
accompanied during the stability study.
RESULTS AND DISCUSSION
The drying method only slightly affected the solid 
residue, as reported previously: 1.3% (w/v) for oven 
dried M. glomerata compared to 1.4% (w/v) for freeze-
dried M. glomerata, and 1.2% (w/v) for oven dried M. 
laevigata to 1.3% (w/v) for freeze-dried M. laevigata. 
The initial chromatographic analysis also showed 
a similar chromatographic profile for each species, 
regardless of the form of drying. However, a marked 
difference in the concentration of the chemical marker, 
coumarin, was observed between species. Another 
compound, chlorogenic acid, was lower in the oven 
dried samples indicating that oven drying resulted in the 
loss of some constituents (Melo, Sawaya, 2015).
The initial concentration of chlorogenic acid in oven 
dried M. glomerata extract was 1348 µg mL-1 and 1934 
µg.mL-1 for the freeze-dried extract. Coumarin values 
for the M. glomerata extracts were below the limit of 
quantitation (LOQ = 3.3 µg mL-1) and therefore could 
not be analysed in this study. For the extract of oven 
dried M. laevigata, a concentration of 775.1 µg mL-1 
coumarin was found and 1131 µg mL-1 for the extract 
of freeze-dried leaves. The concentration of chlorogenic 
acid in extracts of M. laevigata for both drying processes 
was below the limit of quantitation (LOQ = 20.4 µg 
mL-1) and therefore could not be analysed in this study. 
Due to differences in the composition of the extracts of 
both species, coumarin was used as the marker for M. 
laevigata in the stability study and chlorogenic acid in 
M. glomerata.
The initial content of coumarin and chlorogenic 
acid in commercial samples of fluid extract and tincture 
of guaco was also quantified: 358.2 µg mL-1 of coumarin 
and 159.0 µg mL-1 of chlorogenic acid in the fluid extract 
and 232.3 µg mL-1 of coumarin and 143.7 µg mL-1 of 
chlorogenic acid in the tincture of guaco. These results 
were surprisingly different from those of our extracts, 
indicating that the extracts were possibly obtained from 
a mixture of leaves from both species or using the stems, 
because this part of the plant presents coumarin in both 
species, although in different concentration (Costa et. 
al., 2018). These extracts were also submitted to the 
accelerated and long-term stability studies. 
Only chlorogenic acid was quantified in the 
extracts of M. glomerata, as the coumarin concentration 
was below the LOQ. During the long-term stability 
study at 30 ºC (Figure 1), the content of chlorogenic acid 
was not significantly different after the first 3 months 
of the study for extracts of oven dried M. glomerata; 
but was significantly different after this period. The 
same occurred for the accelerated stability study of 
extracts of oven dried M. glomerata (40 ºC). For the 
freeze-dried samples, there was a significant difference 
in the chlorogenic acid content already within the first 
3 months of the long-term stability study (30 ºC); the 
same did not happen for the accelerated stability study. 
Comparing the accelerated and long-term stability 
studies, in 3 months, oven dried samples showed no 
significant difference in the content of chlorogenic acid 
but the freeze-dried samples did. The initially higher 
concentration chlorogenic acid in extracts of freeze-
dried samples was equal to that of oven dried samples 
after 6 months at 40 ºC whereas after 12 months at 30 ºC 
the content of chlorogenic acid was still significantly 
higher in the freeze-dried extracts. Therefore, the higher 
the temperature at which leaves are dried significantly 
affected the content of chlorogenic acid in the M. 
glomerata extracts. 
For the long-term stability study at room 
temperature (22 ºC) in the presence or absence of light 
(Figure 2) the content of chlorogenic acid was not 
significantly different after 3 months for extracts of oven 
dried M. glomerata (p<0.05), but decreased significantly 
afterwards. However, for the extracts of freeze-dried M. 
glomerata, at 22 ºC with and without light, there was a 
significant decrease in the content of chlorogenic acid 
from 3 months onward. No significant differences were 
observed between samples kept in the light or dark. As 
the concentration of all samples dropped over time, after 
12 months there were no significant differences between 
the extracts of oven dried and freeze-dried M. glomerata 
leaves. The average concentration of chlorogenic acid 
in extracts of oven dried and freeze dried leaves M. 
glomerata leaves after 12 months at 30 ºC were 510.4 
µg mL-1 and 577.8 µg mL-1 respectively; after 12 months 
at 22 ºC with light were 468.5 µg mL-1 and 522.0 µg 
mL-1 respectively and after 12 months at 22 ºC without 
light were 496.2 µg mL-1 and 595.9 µg mL-1 respectively. 
These results indicate that the time in storage affected 
the concentration more than the temperature or incidence 
of light, with the freeze-dried leaf extracts generally 
presenting a slightly higher concentration. 
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FIGURE 1 - Variation of the content of chlorogenic acid in extracts of oven dried and freeze-dried M. glomerata leaves. (A) 
long-term stability study at 30 ºC and (B) accelerated stability study at 40 ºC. (*) Indicates no data collected for this group. 
Capital letters indicate statistically significant (p<0.05) differences within the same drying method (0, 3, 6 and 12 months). 
Lowercase letters indicate statistically significant (p<0.05) differences between drying methods at the same time. Numerals 
indicate statistically significant (p<0.05) differences between storage temperatures (30 ºC and 40 ºC). Experiment performed 
in triplicate. Error bars indicate standard deviation.
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FIGURE 2 - Variation of the content of chlorogenic acid in extracts of oven dried and freeze-dried M. glomerata leaves. Long 
term stability study at 22 ºC in the presence of light (A) and absence of light (B). Capital letters indicate statistically significant 
(p<0.05) differences within the same drying method (0, 3, 6 and 12 months). Lowercase letters indicate statistically significant 
(p<0.05) differences between drying methods at the same time. Numerals indicate statistically significant (p<0.05) differences 
between storage with and without light. Experiment performed in triplicate. Error bars indicate standard deviation.
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Coumarin was quantified in the extracts of M. 
laevigata, as the chlorogenic acid concentration was 
below the LOQ. During the long-term stability study 
at 30 ºC and accelerated study at 40 ºC (Figure 3), the 
content of coumarin was not significantly different after 
the first 3 months of the study for oven dried extracts of 
M. laevigata; being significantly different only after this 
period. For the extracts of freeze-dried samples, there 
was a significant decrease in the coumarin content from 
the first 3 months onward. This result is similar to that 
observed for M. glomerata extracts (Figures 1 and 2). 
The concentration of coumarin was initially higher in 
freeze-dried extracts and remained significantly higher 
throughout this study.
The results of the long-term stability study (22 ºC), 
in the presence and absence of light, indicate a significant 
decrease (p<0.05) in the coumarin concentration along 
the year (0, 3, 6 and 12 months) for the extracts of oven 
dried M. laevigata leaves. The same happened for the 
freeze-dried leaf extract, which initially had higher 
coumarin content and remained significantly higher 
throughout the study. No significant differences were 
observed due to the presence of light (Figure 4).
The variation of the chlorogenic acid and 
coumarin contents in commercial samples of fluid 
extract and tincture of guaco submitted to accelerated 
stability study (40 ºC) is shown in Figure 5. The initial 
concentration of both samples was not significantly 
different. In both cases there was a significant increase 
in the coumarin and chlorogenic acid contents 
after 3 months, which is difficult to explain. After 
6 months these concentrations dropped below the 
initial concentrations. This uncommon result was also 
reported by Amaral et al., 2009 who attributed the 
increase in coumarin to solvent loss by evaporation or 
the balance of cis-trans isomers of o-coumaric acid in 
function of the temperature, promoting the cyclization 
of o-coumaric acid into coumarin. However, this does 
not explain why a significant increase was observed 
only in commercial extracts which, if prepared 
according to the Pharmacopoeia, should not have any 
antioxidants or other compounds added. 
The percentages of coumarin content reduction is 
shown in Table I and of chlorogenic acid in Table II. 
According to Brazilian legislation (Brasil, 2005) a 
proposed shelf life of 24 months is only approved if the 
accelerated stability study or long-term study show less 
than 5.0% decrease in the active contents. Should this 
decrease be between 5.1% and 10.0% in the accelerated 
stability study, the proposed shelf life will be reduced 
by half, to 12 months. There was a decrease of far 
more than the 5 or 10%, for coumarin (the chemical 
marker) as well as for chlorogenic after 6 months, for 
the extracts prepared in our laboratory and for the 
commercial samples. Therefore, the shelf life of the M. 
laevigata extracts and commercial extracts, considering 
the decrease in coumarin concentration, should be less 
than 6 months, possibly only 3 months. 
The accelerated and long-term degradation studies 
of M. laevigata extracts, as well as of commercial 
samples indicate that the shelf life of the extracts should 
not be higher than 3 months, considering the decrease 
in coumarin concentration. It can also be noted that the 
storage temperature and light incidence did not strongly 
affect this decrease, as the percentage of reduction of 
coumarin after 12 months at 30 ºC or at 22 ºC with or 
without light were similar. Although chlorogenic acid is 
not an official chemical marker for M. glomerata, the 
decrease in its concentrations followed the same trend 
as observed for coumarin (Table II). It is important 
to study the stability of plant extracts used as active 
ingredients in phytotherapic medicine, as degradation 
of the active principles directly affects the efficacy and 
safety of these products.
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FIGURE 3 - Variation of the content of coumarin in extracts of oven dried and freeze-dried M. laevigata leaves. (A) long-term 
stability study at 30 ºC and (B) accelerated stability study at 40 ºC. (*) Indicates no data collected for this group. Capital letters 
indicate statistically significant (p<0.05) differences within the same drying method (0, 3, 6 and 12 months). Lowercase letters 
indicate statistically significant (p<0.05) differences between drying methods at the same time. Numerals indicate statistically 
significant (p<0.05) differences between storage temperatures (30 ºC and 40 ºC). Experiment performed in triplicate. Error 
bars indicate standard deviation.
Lucilia Vilela de Melo, Alexandra Christine Helena Frankland Sawaya
Page 8/12 Braz. J. Pharm. Sci. 2020;56: e17194
FIGURE 4 - Variation of the content of coumarin in extracts of oven dried and freeze-dried M. laevigata leaves. Long term 
stability study at 22 ºC in the presence of light (A) and absence of light (B). Capital letters indicate statistically significant 
(p<0.05) differences within the same drying method (0, 3, 6 and 12 months). Lowercase letters indicate statistically significant 
(p<0.05) differences between drying methods at the same time. Numerals indicate statistically significant (p<0.05) differences 
between storage with and without light. Experiment performed in triplicate. Error bars indicate standard deviation.
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FIGURE 5 - Variation of the content of chlorogenic acid (A) and coumarin (B) in commercial samples of guaco (Fluid Extract 
and Tincture of guaco) subjected to accelerated stability study (40 ºC). Capital letters indicate statistically significant (p<0.05) 
differences for the same sample lowercase letters indicate statistically significant (p<0.05) differences between samples. 
Experiment performed in triplicate. Error bars indicate standard deviation.
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TABLE I - Percentage of coumarin reduction for the evaluated extracts
Sample % after 3 months % after 6 months % after 12 months
Long term stability study (30 oC)
MLO + 1 - 35 - 62
MLL - 19 - 41 - 68
Accelerated stability study (40 oC)
FE + 60 - 65 N
TG + 61 - 14 N
MLO - 19 - 35 N
MLL - 34 - 46 N
Stability study at room temperature with light (22 oC)
MLO - 22 - 41 - 62
MLL - 35 - 46 - 65
Stability study at room temperature without light (22 oC)
MLO - 26 - 43 - 62
MLL - 39 - 51 - 70
Abbreviations: MLO: M. laevigata oven dried; MLL M. laevigata lyophilized; FE: fluid extract of guaco; TG: tincture of 
guaco; symbol (+): Increase in the content; symbol (-): Decrease in the content; N: Not evaluated.
TABLE II - Percentage of chlorogenic acid reduction for the evaluated extracts
Sample
% after  
3 months
% after  
6 months
% after  
12 months
Long term stability study (30 oC)
MGO + 4 - 42 - 62
MGL - 12 - 48 - 70
Accelerated stability study (40 oC)
FE + 53 - 18 N
TG + 13 - 41 N
MGO + 3 - 36 N
(continuing)
Stability of hydroalcoholic extracts of two species of guaco; Mikania glomerata SPRENG. and Mikania laevigata SCHULTZ. (Asteraceae), by UHPLC-MS
Braz. J. Pharm. Sci. 2020;56: e17194 Page 11/12
TABLE II - Percentage of chlorogenic acid reduction for the evaluated extracts
Sample
% after  
3 months
% after  
6 months
% after  
12 months
MGL - 4 - 50 N
Stability study at room temperature with light (22 oC)
MGO + 2 - 46 - 65
MGL - 17 - 51 - 73
Stability study at room temperature without light (22 oC)
MGO - 2 - 45 - 63
MGL - 19 - 57 - 69
Abbreviations: MGO: oven dried M. glomerata; MGL: freeze dried Mikania glomerata; FE: fluid extract of guaco; TG: Tincture 
guaco; symbol (+): Increase in the content; symbol (-): Decrease in the content; N: Not evaluated.
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